Tags

Type your tag names separated by a space and hit enter

ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations.
Obstet Gynecol. 2004 Nov; 104(5 Pt 1):1119-24.OG

Abstract

Early identification and treatment of all pregnant women with human immunodeficiency virus (HIV) is the best way to prevent neonatal disease. Pregnant women universally should be tested for HIV infection with patient notification as part of the routine battery of prenatal blood tests unless they decline the test (ie, opt-out approach). Repeat testing in the third trimester and rapid HIV testing at labor and delivery are additional strategies to further reduce the rate of perinatal HIV transmission. The Committee on Obstetric Practice makes the following recommendations: follow an opt-out prenatal HIV testing approach where legally possible; repeat offer of HIV testing in the third trimester to women in areas with high HIV prevalence, women known to be at high risk for HIV infection, and women who declined testing earlier in pregnancy, as allowed by state laws and regulations; use conventional HIV testing for women who are candidates for third-trimester testing; use rapid HIV testing in labor for women with undocumented HIV status; and if a rapid HIV test result is positive, initiate antiretroviral prophylaxis (with consent) without waiting for the results of the confirmatory test.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15516421

Citation

ACOG Committee on Obstetric Practice. "ACOG Committee Opinion Number 304, November 2004. Prenatal and Perinatal Human Immunodeficiency Virus Testing: Expanded Recommendations." Obstetrics and Gynecology, vol. 104, no. 5 Pt 1, 2004, pp. 1119-24.
ACOG Committee on Obstetric Practice. ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol. 2004;104(5 Pt 1):1119-24.
ACOG Committee on Obstetric Practice. (2004). ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstetrics and Gynecology, 104(5 Pt 1), 1119-24.
ACOG Committee on Obstetric Practice. ACOG Committee Opinion Number 304, November 2004. Prenatal and Perinatal Human Immunodeficiency Virus Testing: Expanded Recommendations. Obstet Gynecol. 2004;104(5 Pt 1):1119-24. PubMed PMID: 15516421.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. A1 - ,, PY - 2004/11/2/pubmed PY - 2004/12/31/medline PY - 2004/11/2/entrez SP - 1119 EP - 24 JF - Obstetrics and gynecology JO - Obstet Gynecol VL - 104 IS - 5 Pt 1 N2 - Early identification and treatment of all pregnant women with human immunodeficiency virus (HIV) is the best way to prevent neonatal disease. Pregnant women universally should be tested for HIV infection with patient notification as part of the routine battery of prenatal blood tests unless they decline the test (ie, opt-out approach). Repeat testing in the third trimester and rapid HIV testing at labor and delivery are additional strategies to further reduce the rate of perinatal HIV transmission. The Committee on Obstetric Practice makes the following recommendations: follow an opt-out prenatal HIV testing approach where legally possible; repeat offer of HIV testing in the third trimester to women in areas with high HIV prevalence, women known to be at high risk for HIV infection, and women who declined testing earlier in pregnancy, as allowed by state laws and regulations; use conventional HIV testing for women who are candidates for third-trimester testing; use rapid HIV testing in labor for women with undocumented HIV status; and if a rapid HIV test result is positive, initiate antiretroviral prophylaxis (with consent) without waiting for the results of the confirmatory test. SN - 0029-7844 UR - https://www.unboundmedicine.com/medline/citation/15516421/ACOG_committee_opinion_number_304_November_2004__Prenatal_and_perinatal_human_immunodeficiency_virus_testing:_expanded_recommendations_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=15516421.ui DB - PRIME DP - Unbound Medicine ER -